There are indications that the estrogenica vaccine, developed by Oxford University, is no longer used in children. The vaccine is recommended for people between the ages of 6 and 17 …
There are indications that the estrogenica vaccine, developed by Oxford University, is no longer used in children. University researchers say the vaccine is expected to boost immunity in people between the ages of 6 and 17. For this, about 300 ‘child volunteers’ were selected. “The vaccine, known as CH Edox Encove-19, has the strongest immune response in children of this age,” said Endru Pollard, chief investigator at the Oxford Vaccine Trial and pediatrician. He said that many children around the world were not affected by the corona virus and that there were no signs of them becoming ill with the infection. But it remains to be seen how much immunity will increase in those of this age.
He said the new clinical trials could help young children and young people under the age of 17 control SARS-COV-2. Pollard said the astrogenic vaccine will be given to about 240 children later this month. The university said in an e-mail that this was the first time the trial had been held for this age group. It has already been reported that the vaccine is cheaper and easier to transport than other vaccines. The target is to produce 300 crore doses of the vaccine this year – another target is to produce 200 million doses per month by April.
Read more here: Badababs ‘queue’ to foreign countries from India for fear of Kovid, increased ‘count’!
Read more here: Inquiry into Trump’s impeachment in the Senate